This inventor holds 28 USPTO granted patents and 1 EPO patent, primarily in Antibiotic Derivatives. Top assignees: Aventis Pharma S.a., Rhone-Poulenc Rorer S.a., Rhone-Poulenc Sante. Active years: 1983-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Massy, FR (1983 - 1989)
- Bures-sur-Yvette, FR (1994 - 2007)
Company Filing History:
14 out of 377 
8 out of 247 
5 out of 192 
Years Active: 1983-2007
Areas of Expertise:
Title: Jean-Claude Barriere: A Visionary in Pharmaceutical Innovations
Introduction
Jean-Claude Barriere is a prominent inventor based in Bures sur Yvette, France. With an impressive portfolio of 28 patents, his contributions to the pharmaceutical field, particularly in the realm of streptogramin derivatives, stand out as significant advancements in drug composition and formulation.
Latest Patents
Among his most recent patents, Barriere has made noteworthy claims regarding "Streptogramin derivatives and compositions thereof." This invention outlines pharmaceutical compositions that feature Group A streptogramin derivatives of a specified formula and salts, combined with at least one natural Group B streptogramin derivative. Another patent focuses on the "Streptogramin derivatives, their preparation and compositions containing them," revealing the general formula for Group A streptogramin derivatives. His work showcases innovations that could lead to enhanced therapeutic options in the pharmaceutical industry.
Career Highlights
Jean-Claude Barriere has had a distinguished career with notable companies in the pharmaceutical sector. He has worked at Aventis Pharma S.A. and Rhone-Poulenc Rorer S.A., where he has been instrumental in research and development, leading to impactful innovations in drug formulation.
Collaborations
Throughout his career, Barriere has collaborated with talented professionals in his field, including Eric Bacque and Jean-Marc Paris. These partnerships have aided in the advancement of his research and the successful realization of his patents.
Conclusion
Jean-Claude Barriere's contributions to pharmaceutical innovations, particularly through his extensive patent portfolio, reflect a dedication to advancing medical science. His work on streptogramin derivatives holds promise for future pharmacological applications, reinforcing the importance of collaboration and innovation in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile